A5074737994- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac Imaging and Diagnostics
- Venous Thromboembolism Diagnosis and Management
- Acute Myocardial Infarction Research
- Heart Failure Treatment and Management
- Health Systems, Economic Evaluations, Quality of Life
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Cardiovascular Disease and Adiposity
- Coronary Interventions and Diagnostics
- Diabetes Treatment and Management
- Artificial Intelligence in Healthcare
- Machine Learning in Healthcare
- Medication Adherence and Compliance
- Cardiac Valve Diseases and Treatments
- Hormonal Regulation and Hypertension
- Cardiac, Anesthesia and Surgical Outcomes
- Artificial Intelligence in Healthcare and Education
- Coronary Artery Anomalies
- Thyroid Disorders and Treatments
- Cardiovascular Issues in Pregnancy
Aristotle University of Thessaloniki
2019-2025
Ippokrateio General Hospital of Thessaloniki
2023-2025
AHEPA University Hospital
2018-2024
Hippocration General Hospital
2023-2024
Aarhus University Hospital
2019-2021
Abstract Background and Aims Residual leaks are not infrequent after left atrial appendage occlusion. However, there is still uncertainty regarding their prognostic implications. The aim of this study to evaluate the impact residual Methods A literature search was conducted until 19 February 2023. comprised peri-device (PDLs) on transoesophageal echocardiography (TEE) or computed tomography (CT), as well patency CT. Random-effects meta-analyses were performed assess clinical leaks. Results...
Heart failure (HF) remains a major cause of morbidity and mortality worldwide. Recently, significant advances have been made in its treatment; however, diuretics remain the cornerstone managing congestion HF. Although diuretic resistance poses challenge management HF is associated with poor outcomes, only limited alternative pharmaceutical options are available clinical practice. The objective this narrative review to provide comprehensive analysis current evidence on effects sodium-glucose...
Abstract Background There are limited data on the association of diabetes mellitus (DM) and levels glycated hemoglobin (HbA1c) with outcomes in patients atrial fibrillation (AF). Methods This retrospective cohort study included who were recently hospitalized a primary or secondary diagnosis AF from December 2015 through June 2018. Kaplan–Meier curves Cox-regression adjusted hazard ratios (aHR) calculated for outcome all-cause mortality cardiovascular (CV) composite CV death hospitalization....
Mining of electronic health record (EHRs) data is increasingly being implemented all over the world but mainly focuses on structured data. The capabilities artificial intelligence (AI) could reverse underusage unstructured EHR and enhance quality medical research clinical care. This study aims to develop an AI-based model transform into organised, interpretable dataset form a national cardiac patients.CardioMining retrospective, multicentre based large, longitudinal obtained from EHRs...
<sec> <title>BACKGROUND</title> A significant number of individuals undergoing Coronary Computed Tomography Angiography (CCTA) for suspected Artery Disease (CAD) have non-obstructive or no CAD. There is a need clinically proven models that can predict the pre-test probability (PTP) stable CAD and help to identify low-risk individuals. Optimizing patient stratification paramount importance improve diagnostic yield cost-effectiveness. </sec> <title>OBJECTIVE</title> study being carried out...
Background: Selecting the optimal oral anticoagulation (OAC) therapy for elderly patients with atrial fibrillation (AF) remains challenging. Our real-world study investigates clinical factors guiding OAC prescription patterns and compares outcomes between full- reduced-dose direct-acting anticoagulants (DOACs) vitamin K antagonists (VKAs) in this demographic. Methods: This post hoc analysis of MISOAC-AF trial focused on hospitalized AF aged ≥ 75 years prescribed at discharge. Predictors VKA...
Managing dual antiplatelet therapy (DAPT) perioperatively is challenging, especially in patients who have recently undergone percutaneous coronary intervention (PCI). Intravenous agents are recommended these cases. This case series describes the perioperative management of two high bleeding risk with recent PCI undergoing cardiac and non-cardiac surgeries using cangrelor monotherapy.
Background/Objectives: Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a heterogenous clinical entity which differs in pathophysiology, treatment, and prognosis from myocardial obstructive artery disease (MI-CAD) MINOCA mimickers, such as myocarditis or Takotsubo syndrome. This study aimed to compare the characteristics, imaging findings, management strategies, long-term outcomes of patients true MINOCA, MI-CAD, mimickers. Methods: retrospective cohort included 1596...
We aimed to assess the impact of an educational, motivational intervention on adherence oral anticoagulation (OAC) in patients with non-valvular atrial fibrillation (AF).Hospitalized AF who received OAC were randomly assigned usual medical care or a proactive intervention, comprising interviewing, and tailored counselling medication adherence. The primary study outcome was at 1 year, which evaluated according proportion days covered (PDC) by regimens assessed through nationwide registers...
Introduction Myocardial infarction with non-obstructive coronary arteries (MINOCA) occurs in 5%–15% of all patients acute myocardial infarction. Cardiac MR (CMR) and optical coherence tomography have been used to identify the underlying pathophysiological mechanism MINOCA. The role cardiac CT angiography (CCTA) MINOCA, however, has not well studied so far. CCTA can be assess atherosclerotic plaque volume, vulnerable characteristics as pericoronary fat tissue attenuation, which yet Methods...
Background/Objectives: Contradictory results have been reported regarding the influence of obesity on prognosis atrial fibrillation (AF). The present study aimed to explore potential association body mass index (BMI) with clinical outcomes hospitalized patients AF. Methods: In this retrospective, post hoc analysis MISOAC-AF randomized trial, 1113 AF were included and stratified as following: underweight (BMI < 18 kg/m2), normal weight 18–24.9 overweight 25–29.9 obese ≥ 30 kg/m2). primary...
This study sought to develop and validate a risk score predict mortality in patients with atrial fibrillation (AF) after hospitalization for cardiac reasons. The new was derived from prospective cohort of hospitalized concurrent AF. outcome measures were all-cause cardiovascular mortality. Random forest used variable selection. A points model predictor variables developed by weighted Cox regression coefficients internally validated bootstrapping. In total, 1130 AF included. During median...
Atrial fibrillation (AF) is often accompanied by thyroid disease (THD). This study aimed to explore the relationship between THD and occurrence of significant clinical outcomes in patients with AF. post hoc analysis utilized data from MISOAC-AF trial (NCT02941978), which enrolled hospitalized Patients were categorized based on their history into hyperthyroidism, hypothyroidism, or euthyroidism. Cox regression models employed calculate unadjusted adjusted hazard ratios (aHRs). The primary...
Background: Proper anticoagulation is a crucial therapeutic regimen in atrial fibrillation (AF). Objectives: To evaluate the real-life prescriptions of AF patients upon hospital discharge. Methods: We studied 768 with comorbid who were discharged from cardiology ward tertiary hospital. assessed appropriateness oral (OAC) regimens at discharge based on stroke risk (CHA 2 DS -Vasc score), SAMe-TT R (sex, age, medical history, treatment, tobacco, race) score for vitamin K antagonists (VKA), and...